Manchester Financial Inc Edwards Lifesciences Corp Transaction History

Manchester Financial Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 03, 2021	SELL	$78.68 - $90.67 $3,304 - $3,808	-42 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$71.69 - $91.23 $3,010 - $3,831	42 New	42 $4,000
Q3 2020 Oct 15, 2020	SELL	$67.19 - $87.44 $16,125 - $20,985	-240 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$57.54 - $76.95 $9,206 - $12,312	160 Added 200.0%	240 $17,000
Q1 2020 Apr 20, 2020	SELL	$52.41 - $81.0 $1,572 - $2,430	-30 Reduced 27.27%	80 $15,000
Q4 2019 Jan 17, 2020	BUY	$71.7 - $82.09 $7,887 - $9,029	110 New	110 $26,000
Q3 2019 Oct 09, 2019	SELL	$61.55 - $75.43 $4,924 - $6,034	-80 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$55.74 - $64.41 $4,459 - $5,152	80 New	80 $15,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.